James Kasuboski

Luma Group thesis

Whitepapers April 23, 2026 Rebuilding a Brittle Market: Regulatory Reform and the Return of Innovation in Osteoporosis Osteoporosis, a condition where bones become weak and brittle due to loss of bone density, is often seen as a natural part of aging, but it is more accurately a chronic disease caused by disrupted bone remodeling. 10 million Americans over age 50 have osteoporosis, and another 43 million have low bone mass.[1] Despite this, many patients remain undiagnosed and untreated. While existing therapies can reduce fracture risk, they do not provide a safe, effective long-term solution

Sector and stage focus

• Seed: BioTech
• Series A: BioTech
• general: Boston / New England

Is James Kasuboski a fit for your round?

Upload your pitch deck and see whether James Kasuboski appears in your top 20 matches.